Sandoz Antitrust Claims Nixed In Bayer's Yasmin IP Suit
A New York federal judge on Wednesday dismissed antitrust counterclaims brought by drugmaker Sandoz Inc. in Bayer Schering Pharma AG's patent infringement suit over a generic version of oral contraceptive Yasmin,...To view the full article, register now.
Already a subscriber? Click here to view full article